Andere Sprachen Applied Genetic Technologies Corporation

Aktien

A110V2

US03820J1007

AGTC

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Adrenoleukodystrophy Pipeline, Clinical Trials Studies, Emerging Drugs, Mergers and Acquisition, Licensing, Agreements & Collaborations, and Latest News 2023 (Updated)	27.10.23
Applied Genetic Technologies : Termination of Material Agreement - Form 8-K	01.12.22
APPLIED GENETIC TECHNOLOGIES CORP : Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	01.12.22
Syncona Limited Portfolio Company Successfully Completes Tender Offer and Acquisition of Applied Genetic Technologies Corporation	01.12.22
Syncona Limited Portfolio Company Successfully Completes Tender Offer and Acquisition of Applied Genetic Technologies Corporation	01.12.22
Syncona's Achilles says cancer treatment shows promise; seals buy	01.12.22
British Investor Syncona Closes Acquisition of US Biotech Applied Genetic Technologies	01.12.22
Applied Genetic Technologies Corporation(NasdaqGM:AGTC) dropped from NASDAQ Composite Index	01.12.22
Syncona Limited, a fund managed by Syncona Investment Management Limited completed the acquisition of Applied Genetic Technologies Corporation.	30.11.22
APPLIED GENETIC TECHNOLOGIES CORP : Other Events, Financial Statements and Exhibits (form 8-K)	29.11.22
Applied Genetic Technologies Says Syncona Extends Tender Offer Through Wednesday	29.11.22
Syncona Limited Portfolio Company Extends Tender Offer to Acquire Applied Genetic Technologies Corporation	29.11.22
Syncona Limited Portfolio Company Extends Tender Offer to Acquire Applied Genetic Technologies Corporation	29.11.22
TOP NEWS: AstraZeneca to buy Neogene for cancer treatment	29.11.22
Syncona Extends Offer Period For $24 Million Takeover of Applied Genetic Technologies	29.11.22
Applied Genetic Technologies Corporation(NasdaqGM:AGTC) dropped from S&P TMI Index	29.11.22
FINAL REMINDER AGTC Urges Shareholders to Tender Their Shares by November 28, 2022 FINAL REMINDER	28.11.22
FINAL REMINDER AGTC Urges Shareholders to Tender Their Shares by November 28, 2022 FINAL REMINDER	28.11.22
APPLIED GENETIC TECHNOLOGIES CORP : Other Events, Financial Statements and Exhibits (form 8-K)	23.11.22
REMINDER AGTC Urges Shareholders to Tender Their Shares by November 28, 2022 REMINDER	22.11.22

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Applied Genetic Technologies Corporation

Aktien

A110V2

US03820J1007

AGTC

Andere Sprachen

Filter